Garry Nolan, PhD, is an immunologist and professor at Stanford University School of Medicine. He is also a business executive and Executive Director of the Board of the Sol Foundation, a research and advocacy center focused on UAP studies.
There's sort of a dance between the mutations that initiate a tumor and then sort of an evolution of how the tumor eventually learns how to trick the...
I have a mutation called MIDFE318K. It's a mutation that I was born with. It wasn't in my family. And it causes both melanoma and kidney cancer.
Jim Allison here in Houston won the Nobel Prize back in 2018 for understanding one of these turnoff signals that the immune system, that the cancers u...
The problem with that suppression is that you then put yourself at risk of cancer, because what you're doing is you're turning off the immune system's...
There's always a benefit to damage ratio that you're having to deal with, that a drug has a positive outcome, but there are side effects.
Joe Rogan podcast, check it out.
The Joe Rogan Experience.
Train by day, Joe Rogan podcast by night, all day.
Derek, very nice to meet you, sir.
Nice to meet you as well.
Thank you for doing this. I really appreciate it.
Tell everybody what you do.
Tell everybody what your official position is.
AI-generated • May contain errors
Read full transcript
Pixly
